Nautilus Biotechnology shareholders elect Class II directors Mallick, Nazem at annual meeting

• Nautilus Biotechnology held its annual shareholder meeting on June 17, 2026.
• Shareholders selected Parag Mallick, Farzad Nazem to serve as Class II directors through the 2029 annual meeting.
• PricewaterhouseCoopers was ratified as independent registered public accounting firm for the fiscal year ending Dec. 31, 2026.
• Shareholders backed an annual schedule for future advisory votes on executive pay; the company will hold the vote every year.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Nautilus Biotechnology Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001808805-26-000027), on June 18, 2026, and is solely responsible for the information contained therein.